Company intelligence / Profile preview

Hospired

Lake Forest, Illinois, United Stateshospired.net ↗

Ownership: Private
Employees: ~19000
Development stage: Commercial

Overview

Prior to its acquisition by Pfizer, Hospira was the world’s largest producer of generic injectable pharmaceuticals and had significant clinical/commercial success with both small molecules and biologics/biosimilars. It also developed integrated infusion therapy systems used worldwide.

Therapeutic areas: OtherOncologyHematology
Modalities: Small moleculeBiologicMonoclonal antibodyProtein
Industry: Biotech

Partnerships

STADA Arzneimittel AG & BIOCEUTICALS Arzneimittel AG – collaboration on biosimilar erythropoietin for Europe.BresaGen Limited – acquired for protein/peptide manufacturing capabilities supporting biologics/biosimilars program.

Beyond the preview

Go deeper on Hospired.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hospired.

Explore the full profile